Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $199,507 - $260,180
-705 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $182,595 - $292,370
705 New
705 $244,000
Q3 2020

Nov 12, 2020

SELL
$264.77 - $305.71 $239,616 - $276,667
-905 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$258.66 - $342.55 $77,598 - $102,765
-300 Reduced 24.9%
905 $242,000
Q1 2020

May 12, 2020

BUY
$268.85 - $341.04 $106,195 - $134,710
395 Added 48.77%
1,205 $381,000
Q4 2019

Feb 13, 2020

BUY
$220.06 - $304.07 $178,248 - $246,296
810 New
810 $240,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Bluestein R H & CO LLC Portfolio

Follow Bluestein R H & CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bluestein R H & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bluestein R H & CO LLC with notifications on news.